Business Standard

Sun Pharma shares continue to decline

Sun Pharma stock is yet to recover from Wednesday's fall on the bourses when it hit a six-month low after a foreign brokerage firm raised concerns around corporate governance practices

Sun Pharma
Premium

FILE PHOTO: A bird flies past the logo of Sun Pharma installed on the facade of its corporate office in Mumbai | Photo: Reuters

Bs Reporter Mumbai
Sun Pharma stock is yet to recover from Wednesday's fall on the bourses when it hit a six-month low after a foreign brokerage firm raised concerns around corporate governance practices at the drug major. The stock was further down 1.31 per cent from Wednesday's closing in morning trade. 

The stock is currently trading at Rs 480 a piece on BSE. On November 28 Sun Pharma stock fell 3 per cent during the day but recovered partially to close at Rs 486.35 a piece on the BSE, down 1.47 per cent. 

An email sent to Sun Pharma was not immediately answered. 

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in